Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow-derived mesenchymal stromal cell transplantation

bone marrow-derived mesenchymal stromal cells (BM-MSCs) · Royan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous bone marrow-derived mesenchymal stromal cell transplantation, covering 2016-07-20 to 2016-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease [Phase 1]

See pricing